← Back to headlines
Zelluna reports favorable safety data and first patient dosed in Q2 2026
Zelluna's Q2 2026 slides indicate that the first patient has been dosed and initial safety data appears favorable.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
